'Cancer doesn't have an age': Genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24

Health (United Kingdom)

Volumn 16, Issue 6, 2012, Pages 636-654

  Werner Lin, Allison ^a   Hoskins, Lindsey M ^b   Doyle, Maya H ^a   Greene, Mark H ^b  

^a NEW YORK UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

BRCA1 2 genetic mutations; Family relations; Human development; Risk management; Risk perceptions

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; BREAST TUMOR; ELECTIVE SURGERY; FEMALE; GENETIC SCREENING; GENETICS; HETEROZYGOTE DETECTION; HUMAN; ISOLATION AND PURIFICATION; OVARY TUMOR; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; RISK REDUCTION; SOCIAL SUPPORT; THEORETICAL MODEL; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; HETEROZYGOTE DETECTION; HUMANS; MODELS, THEORETICAL; OVARIAN NEOPLASMS; QUALITATIVE RESEARCH; RISK REDUCTION BEHAVIOR; SOCIAL SUPPORT; SURGICAL PROCEDURES, ELECTIVE; YOUNG ADULT;

EID: 84883234790     PISSN: 13634593     EISSN: 14617196     Source Type: Journal    
DOI: 10.1177/1363459312442420     Document Type: Article

References (54)

1. Allen AL (1999) Genetic privacy: Emerging concepts and values. In: Rothstein MA (ed.) Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. New Haven, CT: Yale University Press.
2. Arnett JJ (2000) Emerging adulthood: A theory of development from the late teens through the twenties. American Psychologist 55(5): 469-480.
3. Arnett JJ and Galambos NL (2003) Culture and conceptions of adulthood. New Directions for Child & Adolescent Development 100: 91-98.
4. Beeson D (1997) Nuance, complexity, and context: Qualitative methods in genetic counselingresearch. Journal of Genetic Counseling 6(1): 21-43.
5. Borysenko J (1996) A Woman's Book of Life: The Biology, Psychology, and Spirituality of the Feminine Life Cycle. New York: Riverhead Books.
6. Bronfenbrenner U (1979) The Ecology of Human Development: Experiments by Nature and Design. Cambridge, MA: Harvard University Press.
7. Bronfenbrenner U (2005) Making Human Beings Human: Bioecological Perspectives on Human Development. Los Angeles, CA: SAGE.
8. Campeau PM, Foulkes WD and Tischkowitz MD (2008) Hereditary breast cancer: New genetic developments, new therapeutic avenues. Human Genetics 124(1): 31-42.
9. Carter EA and McGoldrick M (1999) Overview: The expanded family life cycle: Individual, family, and social perspectives. In: Carter EA and McGoldrick M (eds) The Expanded Family Life Cycle: Individual, Family, and Social Perspectives. Boston, MA: Allyn and Bacon, pp. 1-26.
10. Charmaz K (2000) Grounded theory: Objectivist and constructivist methods. In: Denzin NK and Lincoln YS (eds) Handbook of Qualitative Research. Los Angeles: SAGE, pp. 509-536.
11. Chen S and Parmigiani G (2007) Meta-Analysis of BRCA1 and BRCA2 penetrance. Journal of Clinical Oncology 25(11): 1329-1333.
12. Chen S, Iverson ES, Friebel T, et al. (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. Journal of Clinical Oncology 24(6): 863-871.
13. Clark AS and Domchek SM (2011) Clinical management of hereditary breast cancer syndromes. Journal of Mammary Gland Biology and Neoplasia 16(1): 17-25.
14. DeMarco T, Peshkin B, Valdimarsdottir H, Patenaude A, Schneider K and Tercyak KP (2008) Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children. Journal of Genetic Counseling 17(3): 283-287.
15. Evans JP, Skrzynia C, Susswein L and Harlan M (2005/2006) Genetics and the young woman with breast cancer. Breast Disease 23: 17-19.
16. Halbert CH, Kessler L, Wileyto EP, et al. (2006) Breast cancer screening behaviors among African American women with a strong family history of breast cancer. Preventive Medicine: An International Journal Devoted to Practice and Theory 43(5): 385-388.
17. Hallowell N and Lawton J (2002) Negotiating present and future selves: Managing the risk of hereditary ovarian cancer by prophylactic surgery. health: 6(4): 423-443.
18. Hamilton R, Williams JK, Bowers BJ and Calzone K (2009) Life trajectories, genetic testing, and risk-reduction decisions in 18-39 year old women at risk for hereditary breast and ovariancancer. Journal of Genetic Counseling 18: 147-159.
19. Hendrick RE (2010) Radiation doses and cancer risks from breast imaging studies. Radiology 257: 246-253.
20. Hill C, Thompson BJ and Williams EN (1997) A guide to conducting consensual qualitative research. The Counseling Psychologist 25(4): 517-572.
21. Hinds PS, Vogel RJ and Clarke-Steffen L (1997) The possibilities and pitfalls of doing secondary analysis of a qualitative data set. Qualitative Health Research 7(3): 408-424.
22. Hoskins LM and Greene MH (2012) Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers. Qualitative Health Research, in press.
23. Hoskins LM, Roy KM and Greene MH (2012) Toward a new understanding of risk perception among young female BRCA1/2 'previvors'. Families, Systems & Health 30(1): 32-46.
24. Hoskins LM, Roy K, Peters JA, Loud J and Greene MH (2008) Disclosure of positive BRCA 1/2-mutation status in young couples: The journey from uncertainty to bonding through partner support. Families, Systems & Health 26: 296-316.
25. Humphrey LL, Helfand M, Chan BK, et al. (2002) Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 137(5 Part 1): 347-360.
26. Kapingst KA, Lachance CR and Condit CM (2009) Beliefs about heritability of cancer and health information seeking and preventive behaviors. Journal of Cancer Education 24: 351-356.
27. Kauff ND, Domchek SM, Friebel TM, et al. (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study. Journal of Clinical Oncology 26: 1331-1337.
28. Land CE (1995) Studies of cancer and radiation dose among atomic bomb survivors: The example of breast cancer. JAMA 274: 402-407.
29. Lindenmeyer A, Griffiths F and Hodson G (2010) 'The family is part of the treatment really': A qualitative exploration of collective health narratives in families. health: 15(4): 401-415.
30. Lippman A (1999) Choice as a risk to women's health. Health, Risk & Society 1(3): 281-291.
31. Lynch HT, Casey MJ, Snyder CL, et al. (2009) Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management. Molecular Oncology 3(2): 97-137.
32. Mandelson M, Oestreicher N, Porter PL, et al. (2000) Breast density as a predictor of mam-mographic detection: Comparison of interval- and screen-detected cancers. Journal of the National Cancer Institutes 92: 1081-1087.
33. McPherson G and Thorne S (2006) Exploiting exceptions to enhance interpretive qualitative health research: Insight from a study of cancer communication. International Journal of Qualitative Methods 5(2): 1-11.
34. Nanda R, Schumm LP, Cummings S, et al. (2005) Genetic testing in an ethnically diverse cohort of high-risk women: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. Journal of the American Medical Association 294(15): 1925-1933.
35. Narod SA (2010) BRCA mutation in the management of breast cancer: The state of the art. Nature Reviews Clinical Oncology 7(12): 702-707.
36. Newcomb PA, Weiss NS, Storer BE, et al. (1991) Breast self-examination in relation to the occurrence of advanced breast cancer. Journal of the National Cancer Institute 83(4): 260-265.
37. Petrucelli N, Daly MD and Feldman GL (2010) Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genetic Medicine 12(5): 245-259.
38. Pruthi S, Gostout BS and Lindor NM (2010) Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer. Mayo Clinic Proceedings 85(12): 1111-1120.
39. Samuel JC and Ollila DW (2005/2006). Prophylaxis and screening options: Recommendations for young women with BRCA mutations. Breast Disease 23: 31-35.
40. Schwartz MD, Peshkin BN, Tercyak KP, Taylor KL and Valdimarsdottir H (2005) Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Health Psychology 24(4 Suppl): S78-84.
41. Stratton JF, Thompson T, Bobrow L, et al. (1999) Genetic epidemiology of early-onset epithelial ovarian cancer: A population-based study. American Journal of Human Genetics 65: 1725-1732.
42. Strauss A and Corbin J (1998) Basics of Qualitative Research. Los Angeles, CA: SAGE.
43. Ten Have HAMJ (2001) Genetics and culture: The geneticization thesis. Medicine, Health Care, and Philosophy 4(3): 295-304.
44. Thorne S, Jensen L, Kearney MH, Noblit G and Sandelowski M (2004) Qualitative metasyn-thesis: Reflections on methodological orientation and ideological agenda. Qualitative Health Research 14(10): 1342-1365.
45. Thorne S, Reimer KS and MacDonald-Emes J (1997) Interpretive description: A non-categorical qualitative alternative for developing nursing knowledge. Research in Nursing & Health 20: 169-177.
46. Tiggemann M and Pennington B (1990) The development of gender differences in body-size dissatisfaction. Australian Psychologist 25(3): 306-313.
47. Trepanier A, Ahrens M, McKinnon W, et al. (2004) Genetic cancer risk assessment and counseling: Recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling 13(2): 83-114.
48. US Census (2009) Estimated Median Age at First Marriage, by Sex: 1890 to 2009. Washington, DC: United States Census Bureau.
49. Van Oostrom I, Meijers-Heijboer H, Lodder LN, et al. (2003) Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. Journal of Clinical Oncology 21: 3867-3874.
50. Watson M, Foster C, Eeles R, et al. (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. British Journal of Cancer 91(10): 1787-1794.
51. Werner-Lin A (2007) Danger zones: Risk perceptions of young women from families with hereditary breast and ovarian cancer. Family Process 46(3): 335-349.
52. Werner-Lin A (2008a) Beating the biological clock: The compressed family life cycle of young women with BRCA mutations. Social Work in Health Care 47(4): 416-437.
53. Werner-Lin A (2008b) Formal and informal support needs of young women with BRCA mutations. Journal of Psychosocial Oncology 26(4): 111-133.
54. Werner-Lin A (2010) Building the cancer family: Family planning in the context of inherited breast and ovarian cancer risk. Journal of the Society for Social Work and Research 1(1): 26-38.